If a pregnant patient uses anticonvulsants, how does spina bifida risk change?

Prepare for the Pediatrics Rehabilitation Exam 2 with dynamic study tools. Utilize flashcards and multiple choice questions, each with hints and explanations, to ensure you're ready. Dive into the essentials for success!

Multiple Choice

If a pregnant patient uses anticonvulsants, how does spina bifida risk change?

Explanation:
Exposure to anticonvulsants during early pregnancy raises the risk of neural tube defects, including spina bifida. Valproic acid carries the strongest association, and the risk increases with higher doses and when multiple anticonvulsants are used. Neural tube closure occurs in the first month of gestation, so disruption during that window can lead to defects. Many anticonvulsants interfere with folate metabolism, underscoring the rationale for folic acid supplementation before conception. If possible, use the lowest effective dose in monotherapy and consider switching to a safer agent before pregnancy; continue folate support. In short, the risk increases with anticonvulsant exposure, rather than decreasing, staying the same, or being unknown.

Exposure to anticonvulsants during early pregnancy raises the risk of neural tube defects, including spina bifida. Valproic acid carries the strongest association, and the risk increases with higher doses and when multiple anticonvulsants are used. Neural tube closure occurs in the first month of gestation, so disruption during that window can lead to defects. Many anticonvulsants interfere with folate metabolism, underscoring the rationale for folic acid supplementation before conception. If possible, use the lowest effective dose in monotherapy and consider switching to a safer agent before pregnancy; continue folate support. In short, the risk increases with anticonvulsant exposure, rather than decreasing, staying the same, or being unknown.

Subscribe

Get the latest from Examzify

You can unsubscribe at any time. Read our privacy policy